*SB0631.2*
February 8, 2019
SENATE BILL No. 631_____
DIGEST OF SB 631 (Updated February 5, 2019 3:25 pm - DI 106)
Citations Affected: IC 35-31.5; IC 35-48.
Synopsis: Drug classifications and drug schedules. Adds numeroussubstances to the definition of "synthetic drug". Adds epidiolex andbrivaracetam to Schedule V. Specifies that dronabinol is a Schedule IIcontrolled substance only in oral solution. Defines "fentanyl relatedsubstance" and adds it to Schedule I. Moves certain fentanyl relatedsubstances from the definition of "synthetic drugs" in Schedule II toSchedule I. Adds Thiafentanil to Schedule II.
Effective: July 1, 2019.
Young M, Bohacek
January 15, 2019, read first time and referred to Committee on Rules and LegislativeProcedure.
January 16, 2019, amended; reassigned to Committee on Corrections and Criminal Law.February 7, 2019, amended, reported favorably — Do Pass.
SB 631—LS 7594/DI 13
February 8, 2019
First Regular Session of the 121st General Assembly (2019)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the IndianaConstitution) is being amended, the text of the existing provision will appear in this style type,additions will appear in this style type, and deletions will appear in this style type. Additions: Whenever a new statutory provision is being enacted (or a new constitutionalprovision adopted), the text of the new provision will appear in this style type. Also, theword NEW will appear in that style type in the introductory clause of each SECTION that addsa new provision to the Indiana Code or the Indiana Constitution. Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflictsbetween statutes enacted by the 2018 Regular and Special Session of the General Assembly.
SENATE BILL No. 631
A BILL FOR AN ACT to amend the Indiana Code concerningcriminal law and procedure.
Be it enacted by the General Assembly of the State of Indiana:
1 SECTION 1. IC 35-31.5-2-130.5 IS ADDED TO THE INDIANA2 CODE AS A NEW SECTION TO READ AS FOLLOWS3 [EFFECTIVE JULY 1, 2019]: Sec. 130.5. "Fentanyl related4 substance", for purposes of IC 35-48, has the meaning set forth in5 IC 35-48-1-16.6.6 SECTION 2. IC 35-31.5-2-321, AS AMENDED BY P.L.89-2018,7 SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE8 JULY 1, 2019]: Sec. 321. "Synthetic drug" means:9 (1) a substance containing one (1) or more of the following
10 chemical compounds, including an analog of the compound:11 (A) JWH-015 ((2-Methyl-1-propyl-1H-12 indol-3-yl)-1-naphthalenylmethanone).13 (B) JWH-018 (1-pentyl-3-(1-naphthoyl)indole).14 (C) JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole).15 (D) JWH-07316 (naphthalen-1-yl-(1-butylindol-3-yl)methanone).17 (E) JWH-081 (4-methoxynaphthalen- 1-yl- (1-pentylindol-
SB 631—LS 7594/DI 13
2
1 3-yl)methanone).2 (F) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).3 (G) JWH-200 ((1-(2-morpholin-4-ylethyl)indol-3-yl)-4 naphthalen-1-yl-methanone).5 (H) JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole).6 (I) JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole).7 (J) JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).8 (K) HU-210 ((6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl-9 3-(2-methyloctan-2-yl)-
10 6a,7,10,10a-tetrahydrobenzo [c]chromen- 1-ol).11 (L) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)- 6,6-dimethyl-12 3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo13 [c]chromen-1-ol).14 (M) HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-15 (2-methyloctan- 2-yl)phenyl]-16 7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol).17 (N) HU-331 (3-hydroxy-2- [(1R,6R)-3-methyl-6-18 ( 1 - m e t h y l e t h e n y l ) - 2 - c y c l o h e x e n - 1 - y l ] - 519 -pentyl-2,5-cyclohexadiene-1,4-dione).20 (O) CP 55,94021 (2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-22 5- (2-methyloctan-2-yl)phenol).23 (P) CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5-24 (2-methyloctan-2-yl)phenol) and its homologues, or25 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)26 phenol), where side chain n=5, and homologues where side27 chain n=4, 6, or 7.28 (Q) WIN 55212-229 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)30 pyrrolo [1,2,3-de)- 1,4- benzoxazin-31 6-yl]-1-napthalenylmethanone).32 (R) RCS-4 ((4-methoxyphenyl)33 (1-pentyl-1H-indol-3-yl)methanone).34 (S) RCS-8 (1-(1-(2-cyclohexylethyl)-1H-35 indol-3-yl)-2-(2-methoxyphenyl)ethanone).36 (T) 4-Methylmethcathinone. Other name: mephedrone.37 (U) 3,4-Methylenedioxymethcathinone. Other name:38 methylone.39 (V) Fluoromethcathinone.40 (W) 4-Methoxymethcathinone. Other name: methedrone.41 (X) 4-Ethylmethcathinone (4-EMC).42 (Y) Methylenedioxypyrovalerone. Other name: MDPV.
SB 631—LS 7594/DI 13
3
1 (Z) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole.2 (AA) JWH-098, or3 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole.4 (BB) JWH-164, or5 1-pentyl-3-(7-methoxy-1-naphthoyl)indole.6 (CC) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole.7 (DD) JWH-201, or8 1-pentyl-3-(4-methoxyphenylacetyl)indole.9 (EE) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole.
10 (FF) AM-694, or11 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.12 (GG) CP 50,556-1, or13 [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpe14 ntan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-115 -yl] acetate.16 (HH) Dimethylheptylpyran, or DMHP.17 (II) 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP.18 (JJ) 6-APB [6-(2-aminopropyl)benzofuran].19 (LL) 7-hydroxymitragynine.20 (MM) á-PPP [á-pyrrolidinopropiophenone].21 (NN) á-PVP (desmethylpyrovalerone).22 (OO) AM-251.23 (PP) AM-1241.24 (QQ) AM-2201.25 (RR) AM-2233.26 (SS) Buphedrone (á-methylamino-butyrophenone (MABP)).27 (TT) Butylone.28 (UU) CP-47,497-C7.29 (VV) CP-47,497-C8.30 (WW) Desoxypipradol.31 (XX) Ethylone.32 (YY) Eutylone.33 (ZZ) Flephedrone.34 (AAA) JWH-011.35 (BBB) JWH-020.36 (CCC) JWH-022.37 (DDD) JWH-030.38 (EEE) JWH-182.39 (FFF) JWH-302.40 (GGG) MDAI [5,6-methylenedioxy-2-aminoindane].41 (HHH) Mitragynine.42 (III) Naphyrone.
SB 631—LS 7594/DI 13
4
1 (JJJ) Pentedrone.2 (LLL) Pentylone.3 (MMM) Methoxetamine4 [2-(3-methoxyphenyl)-2-(ethylamino)- cyclohexanone].5 (NNN) A796,2606 [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-7 (2,2,3,3-tetramethylcyclopropyl)methanone].8 (OOO) AB-001[(1s,3s)-admantan-1-yl)9 (1-pentyl-1H-indol-3-yl)methanone] or [1-Pentyl-3-
10 (1-adamantoyl)indole].11 (PPP) AM-356 [Methanandamide].12 (QQQ) AM 1248 [1-[(1-methyl-2- piperidinyl) methyl]-13 1H-indol-3-yl] tricyclo[3.3.1.13,7] dec-1-yl-methanone]or14 [(1-[(N-methylpiperindin-2-yl)15 Methyl]-3-(Adamant-1-oyl)indole)].16 (RRR) AM 2233 Azepane isomer [(2-iodophenyl)17 (1-(1-methylazepan-3-yl)- 1H-indol-3-yl)methanone].18 (SSS) CB-13 [1-Naphthalenyl19 [4-(pentyoxy)- 1-naphthalenyl]methanone].20 (TTT) UR-144 [(1-pentyl-1H-indol-3-yl)21 (2,2,3,3-tetramethylcyclopropyl)-methanone].22 (UUU) URB 597 [(3'-(aminocarbonyl) [1,1'-biphenyl]-3-yl)-23 cyclohexylcarbamate].24 (VVV) URB602 [[1,1'-biphenyl]- 3-yl-carbamic acid,25 cyclohexyl ester].26 (WWW) URB 754 [6-methyl-2-[(4-methylphenyl)27 amino]-1-benzoxazin-4-one].28 (XXX) XLR-11 or 5-fluoro UR-14429 (1-(5-fluoropentyl)-1H-indol-3-yl)30 (2,2,3,3-tetramethylcyclopropyl)methanone].31 ( Y Y Y ) A KB 4 8 ( O t h e r n a m e s i n c l u d e :32 N-Adamantyl-1-pentyl-1H-Indazole-3-carboxamide;33 1-pentyl-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-indazole-3-34 carboxamide).35 (ZZZ) 25I-NBOMe (Other names include:36 4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-37 benzeneethanamine);38 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)39 methyl]ethanamine).40 (AAAA) 2C-C-NBOMe (Other names include:41 25C-NBOMe;42 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
SB 631—LS 7594/DI 13
5
1 methyl]ethanamine;2 2,5-Dimethoxy-4-chloro-N-(2-methoxybenzyl)3 phenethylamine).4 (BBBB) 2NE-1 (Other names include: 1-Pentyl-3-5 (1-adamantylamido)indole).6 (CCCC) STS-135 (Other names include:7 N-Adamantyl-1-fluoropentylindole-3- carboxamide8 (1-5-fluoropentyl)-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-9 indole-3-carboxamide).
10 (DDDD) PB-22 (Other names include: 1-Pentyl-8-quinolinlyl11 ester-1H-indole-2-carboxylic acid).12 (EEEE) 5-Fluoro-PB-22 (Other names include:13 1-(5-Fluropentyl)-8-quinolinyl ester1H-indole-3-carboxylic14 acid).15 (FFFF) Benocyclidine (Other names include: BCP, BTCP, and16 Benzothiophenylcyclohexylpiperidine).17 (GGGG) 25B-NBOMe (Other names include: 2C-B-NBOMe18 and 4-Bromo-2,19 5-dimenthoxy-N-[(2-Methozyphenyl)methyl]20 benzeneethanamine).21 (HHHH) APB (Other names include: (2-Aminopropyl)22 Benzofuran).23 (IIII) AB-PINACA24 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-25 indazole-3-carboxamide.26 (JJJJ) AB-FUBINACA27 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-28 1H-indazole-3-carboxamide).29 (KKKK) ADB-PINACA30 (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-in31 daole-3-carboxamide).32 (LLLL) Fluoro ADBICA (N-(1-Amino-3,3-33 dimethyl-1-oxobutan-2-yl)-(fluoropentyl)-1H-indole-3-34 carboxamide).35 (MMMM) APDB (Other names include: -EMA,36 -Desoxy-MDA, and (2-Aminopropyl)-2,3-37 dihydrobenzofuran).38 (NNNN) THJ-2201 (Other names include: AM2201 indazole39 analog, Fluoropentyl-JWH-018 indazole, and40 5-Fluoro-THJ-018).41 (OOOO) AM 2201 benzimidazole analog (Other names42 include: FUBIMINA, FTHJ, and (1-(5-fluoropentyl)-1H-
SB 631—LS 7594/DI 13
6
1 benzo[d]imidazol-2-yl)(naphthalene-1-yl)methanone).2 (PPPP) MN-25 (Other names include: 7-methoxy-1-3 [2-(4-morpholinyl)ethyl]-N-[1S, 2S, 4R)-1,3,3-4 trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide5 and UR-12).6 (QQQQ) FUB-PB-22 (Other names include:7 Quinolin-8-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).8 (RRRR) FUD-PB-22 (Other names include:9 Naphthalen-1-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
10 (SSSS) 5-Fluoro-AB-PINACA (Other names include:11 AB-PINACA 5-fluoro analog and N-(1-amino-3-methyl1-12 oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-13 carboxaminde).14 (TTTT) 4-MePPP (Other names inc lude :15 4-methyl-alpha-pyrrolidinopropiophenone).16 (UUUU) alpha-PBP (Other names include:17 Alpha-pyrrolidinobutiophenone).18 (VVVV) AB-CHMINACA (Other names include:19 (N-[1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethy20 l)-1H-indazole-3-carboxamide).21 (WWWW) Acetyl fentanyl (Other names include:22 N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide).23 ( X X X X ) ( W W W W ) M e x e d r o n e24 (3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-one).25 (XXXX) MT-45,26 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine).27 (YYYY) methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-28 carboxamido) -3,3-dimethylbutanoate [5F-ADB;29 5F-MDMB-PINACA].30 (ZZZZ) methyl 2-(1-(5-fluoropentyl)-1H- indazole-3-31 carboxamido)-3-methylbutanoate [5F-AMB].32 (AAAAA) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)33 -1-(4-fluorobenzyl)- 1H-indazole-3-carboxamide34 [ADB-FUBINACA].35 (BBBBB) N-(adamantan-1-yl)-1-(5-fluoropentyl)-36 1H-indazole-3- carboxamide [5F-APINACA, 5F-AKB48].37 (CCCCC) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-38 carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA,39 MMB-CHMINACA].40 ( D D DDD) me t hy l 2 - ( 1 - ( 4 - f l u o r o b e n z y l ) -41 1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate42 [MDMB-FUBINACA].
SB 631—LS 7594/DI 13
7
1 (EEEEE) N-(1-amino-3,3-dimethyl-1 -oxobutan-2-yl)-1-2 (cyclohexylmethyl)- 1 H-indazole-3-carboxamide3 [MAB-CHMINACA and ADB-CHMINACA].4 (FFFFF) Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-5 3-carboxamido)- 3-methylbutanoate [FUB-AMB,6 MMB-FUBINACA, AMB-FUBINACA].7 (GGGGG) 3,4-dichloro-N-[(1dimethylamino)cyclohexylme8 thyl]benzamide) [AH7921].9 (HHHHH) Naphthalen-1-yl 1-(5-fluoropentyl)-1
10 H-indole-3-carboxylate (trivial name: NM2201; CBL2201)11 (IIIII) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-112 H- i ndazo l e - 3 - ca r bo xa mi de ( t r i v i a l na me:13 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINA14 CA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA;15 SGT-78).16 (JJJJJ) methyl 2 - ( 1- (cyc lohexylmethyl ) -117 H-indole-3-carboxamido)-3-methylbutanoate (trivial18 names: MMB-CHMICA, AMB-CHMICA).19 (KKKKK) 20 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-121 H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name:22 5F-CUMYL-P7AICA).23 (LLLLL) N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-p24 entanone (N-ethylpentylone, ephylone).25 (MMMMM) Synthetic cathinone,26 1-(1,3-benzodioxol-5-yl)-2- (ethylamino)- pentan-1-one27 (N-ethylpentylone, ephylone) and its optical, positional,28 and geometric isomers, salts, and salts of isomers.29 (2) Any compound structurally derived from30 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by31 substitution at the nitrogen atom of the indole ring by alkyl,32 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,33 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or34 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-35 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether36 or not further substituted in the indole ring to any extent and37 whether or not substituted in the naphthyl ring to any extent.38 (3) Any compound structurally derived from 3-(1-naphthoyl)39 pyrrole by substitution at the nitrogen atom of the pyrrole ring by40 alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,41 cycloalkylethyl , 1-(N-methyl-2-piperidinyl)methyl,42 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl,
SB 631—LS 7594/DI 13
8
1 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl2 group, whether or not further substituted in the pyrrole ring to any3 extent and whether or not substituted in the naphthyl ring to any4 extent.5 (4) Any compound structurally derived from6 1-(1-naphthylmethyl)indene by substitution at the 3-position of7 the indene ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,8 c y c l o a l k y l m e t h y l , c y c l o a l k y l e t h y l ,9 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
10 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-11 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether12 or not further substituted in the indene ring to any extent and13 whether or not substituted in the naphthyl ring to any extent.14 (5) Any compound structurally derived from 3-phenylacetylindole15 by substitution at the nitrogen atom of the indole ring with alkyl,16 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,17 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or18 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-19 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether20 or not further substituted in the indole ring to any extent and21 whether or not substituted in the phenyl ring to any extent.22 (6) Any compound structurally derived from23 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position24 of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,25 c y c l o a l k y l m e t h y l , c y c l o a l k y l e t h y l ,26 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or27 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-28 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether29 or not substituted in the cyclohexyl ring to any extent.30 (7) Any compound containing a 3-(benzoyl)indole structure with31 substitution at the nitrogen atom of the indole ring by alkyl,32 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,33 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or34 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-35 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether36 or not further substituted in the indole ring to any extent and37 whether or not substituted in the phenyl ring to any extent.38 (8) Any compound, except bupropion or a compound listed under39 a different schedule, structurally derived from40 2-aminopropan-1-one by substitution at the 1-position with either41 phenyl, naphthyl, or thiophene ring systems, whether or not the42 compound is further modified:
SB 631—LS 7594/DI 13
9
1 (A) by substitution in the ring system to any extent with alkyl,2 alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide3 substituents, whether or not further substituted in the ring4 system by one or more other univalent substituents;5 (B) by substitution at the 3-position with an acyclic alkyl6 substituent;7 (C) by substitution at the 2-amino nitrogen atom with alkyl,8 dialkyl, benzyl, or methoxybenzyl groups; or9 (D) by inclusion of the 2-amino nitrogen atom in a cyclic
10 structure.11 (9) Any compound structurally derived from 3-tetramethyl12 cyclopropanoylindole with substitution at the nitrogen atom of the13 indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,14 c y c l o a l k y l m e t h y l , c y c l o a l k y l e t h y l ,15 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl) ethyl,16 1-(N-methyl-2-pyrrolidinyl) methyl, 1-(N-methyl-3-17 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether18 or not further substituted in the indole ring to any extent and19 whether or not substituted in the tetramethylcyclopropyl ring to20 any extent.21 (10) Any compound containing a N-(1-adamantyl)-22 1H-indazole-3-carboxamide structure with substitution at the23 nitrogen atom of the indazole ring by an alkyl, haloalkyl,24 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,25 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,26 1 - ( N - m e t h y l - 2 - p y r r o l i d i n y l ) m e t h y l ,27 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl28 group, whether or not further substituted at the nitrogen atom of29 the carboxamide to any extent, whether or not further substituted30 in the indazole ring to any extent, and whether or not further31 substituted on the adamantyl ring system to any extent. An32 example of this structural class includes AKB48.33 (11) Any compound containing a N-(1-adamantyl)-34 1H-indole-3-carboxamide structure with substitution at the35 nitrogen atom of the indole ring by an alkyl, haloalkyl,36 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,37 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,38 1 - ( N - m e t h y l - 2 - p y r r o l i d i n y l ) m e t h y l ,39 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl40 group, whether or not further substituted at the nitrogen atom of41 the carboxamide to any extent, whether or not further substituted42 in the indole ring to any extent, and whether or not further
SB 631—LS 7594/DI 13
10
1 substituted on the adamantyl ring system to any extent. An2 example of this structural class includes STS-135.3 (12) Any compound containing a 3-(1-adamantoyl)indole4 structure with substitution at the nitrogen atom of the indole ring5 by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,6 cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or7 2-(4-morpholinyl)ethyl, 1-(N-methyl-2- pyrrolidinyl)methyl,8 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl9 group, whether or not further substituted on the adamantyl ring
10 system to any extent. An example of this structural class includes11 AM-1248.12 (13) Any compound determined to be a synthetic drug by rule13 adopted under IC 25-26-13-4.1.14 SECTION 3. IC 35-48-1-16.6 IS ADDED TO THE INDIANA15 CODE AS A NEW SECTION TO READ AS FOLLOWS16 [EFFECTIVE JULY 1, 2019]: Sec. 16.6. "Fentanyl related17 substance" means any substance not listed in schedule I through V18 of IC 35-48-2 that is structurally related to fentanyl by one (1) or19 more of the following modifications:20 (1) Replacement of the phenyl portion of the phenethyl group21 by any monocycle, whether or not further substituted in or on22 the monocycle.23 (2) Substitution in or on the phenethyl group with alkyl,24 alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro25 groups.26 (3) Substitution in or on the piperidine ring with alkyl,27 alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino,28 or nitro groups.29 (4) Replacement of the aniline ring with any aromatic30 monocycle whether or not further substituted in or on the31 aromatic monocycle.32 (5) Replacement of the N-propionyl group by another acyl33 group.34 SECTION 4. IC 35-48-2-4, AS AMENDED BY P.L.89-2018,35 SECTION 2, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE36 JULY 1, 2019]: Sec. 4. (a) The controlled substances listed in this37 section are included in schedule I.38 (b) Opiates. Any of the following opiates, including their isomers,39 esters, ethers, salts, and salts of isomers, esters, and ethers, unless40 specifically excepted by rule of the board or unless listed in another41 schedule, whenever the existence of these isomers, esters, ethers, and42 salts is possible within the specific chemical designation:
SB 631—LS 7594/DI 13
11
1 4-fluoroisobutyryl fentanyl2 Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-3 piperidinyl]-N-phenylacetamide) (9815)4 A c e t y l f e n t a ny l ( Ot he r na me s i nc l ude :5 N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)6 Acetylmethadol (9601)7 Acrylfentanyl. Other name: N-(1-phenethylpiperidin-4-yl)-8 N-phenylacrylamide9 Allylprodine (9602)
10 Alpha-methylthiofentanyl (N-[1-methyl-2-(2-11 thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)12 Alphacetylmethadol (9603)13 Alphameprodine (9604)14 Alphamethadol (9605)15 Alphamethylfentanyl (9814)16 Benzethidine (9606)17 Beta-hydroxy-3-methylfentanyl (9831). Other name:18 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl19 ]-N-phenylpropanamide20 Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-21 phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)22 Betacetylmethadol (9607)23 Betameprodine (9608)24 Betamethadol (9609)25 Betaprodine (9611)26 Clonitazene (9612)27 C y c l o p e n t y l f e n t a n y l . O t h e r n a m e :28 N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide29 Dextromoramide (9613)30 Diampromide (9615)31 Diethylthiambutene (9616)32 Difenoxin (9168)33 Dimenoxadol (9617)34 Dimepheptanol (9618)35 Dimethylthiambutene (9619)36 Dioxaphetyl butyrate (9621)37 Dipipanone (9622)38 Ethylmethylthiambutene (9623)39 Etonitazene (9624)40 Etoxeridine (9625)41 Fentanyl related substances.42 Furanyl fentanyl.
SB 631—LS 7594/DI 13
12
1 Furethidine (9626)2 Hydroxypethidine (9627)3 I s o b u t y r y l f e n t a n y l . O t h e r n a m e :4 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide5 Ketobemidone (9628)6 Levomoramide (9629)7 Levophenacylmorphan (9631)8 M e t h o x y a c e t y l f e n t a n y l . O t h e r n a m e :9 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
10 3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-11 piperidyl]-N-phenyl-propanimide](9813)12 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-13 piperidinyl]-N-phenylpropanamide) (9833)14 MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)15 Morpheridine (9632)16 N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl),17 including any isomers, salts, or salts of isomers (9818)18 N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl] 25 piperidin-4-yl]-19 N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-20 (2-thienyl)ethyl] -4- piperidinyl]- N-phenylpropanamide,21 (beta-hydroxythiofentanyl)22 N-(4-chlorophenyl)- N-(1-phenethylpiperidin-4-yl)23 isobutyramide (para-chloroisobutyryl fentanyl)24 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)25 acetamide (ocfentanil)26 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4 -yl) butyramide27 (para-fluorobutyryl fentanyl)28 N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also29 known as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide,30 (butyryl fentanyl)31 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl32 fentanyl)33 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin -4-yl)34 butyramide (para-methoxybutyryl fentanyl)35 N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide36 (thenylfentanyl), including any isomers, salts, or salts of isomers37 (9834)38 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide39 (isobutyryl fentanyl)40 N - ( 1 - p h e n e t h y l p i p e r i d i n - 4 - y l ) -41 Nphenylcyclopentanecarboxamide (cyclopentyl fentanyl)42 Noracymethadol (9633)
SB 631—LS 7594/DI 13
13
1 Norlevorphanol (9634)2 Normethadone (9635)3 Norpipanone (9636)4 O c f e n t a n i l . O t h e r n a m e :5 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)6 acetamide7 Ortho-fluorofentanyl or 2-fluorofentanyl. Other name:8 N-(2-fluorophenyl)-N-9 (1-phenethylpiperidin-4-yl)propionamide
10 Para-chloroisobutyryl fentanyl . Other name:11 N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide12 P a r a - f l u o r o b u t yr y l f e n t a n yl . O t h e r n a m e :13 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide14 Para-fluorofentanyl (N-(4-fluorophenyl)-N-15 [1-(2-phenethyl)-4-piperidinyl] propanamide (9812)16 Para-methoxybu t yr yl f en t anyl . Ot he r name :17 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide18 Phenadoxone (9637)19 Phenampromide (9638)20 Phenomorphan (9647)21 Phenoperidine (9641)22 PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)23 Piritramide (9642)24 Proheptazine (9643)25 Properidine (9644)26 Propiram (9649)27 Racemoramide (9645)28 T e t r a h yd r o f u r a n y l f e n t a n y l . O t h e r n a m e :29 N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carb30 oxamide31 Thiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4-32 piperidinyl]-propanamide) (9835)33 Tilidine (9750)34 Trimeperidine (9646)35 U47700 (3,4-dichloro- N- [2-dimethylamino)cyclohexyl]-36 N-methyl- benzamide)37 V a l e r y l f e n t a n y l . O t h e r n a m e :38 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide39 (c) Opium derivatives. Any of the following opium derivatives, their40 salts, isomers, and salts of isomers, unless specifically excepted by rule41 of the board or unless listed in another schedule, whenever the42 existence of these salts, isomers, and salts of isomers is possible within
SB 631—LS 7594/DI 13
14
1 the specific chemical designation:2 Acetorphine (9319)3 Acetyldihydrocodeine (9051)4 Benzylmorphine (9052)5 Codeine methylbromide (9070)6 Codeine-N-Oxide (9053)7 Cyprenorphine (9054)8 Desomorphine (9055)9 Dihydromorphine (9145)
10 Drotebanol (9335)11 Etorphine (except hydrochloride salt) (9056)12 Heroin (9200)13 Hydromorphinol (9301)14 Methyldesorphine (9302)15 Methyldihydromorphine (9304)16 Morphine methylbromide (9305)17 Morphine methylsulfonate (9306)18 Morphine-N-Oxide (9307)19 Myrophine (9308)20 Nicocodeine (9309)21 Nicomorphine (9312)22 Normorphine (9313)23 Pholcodine (9314)24 Thebacon (9315)25 (d) Hallucinogenic substances. Unless specifically excepted or26 unless listed in another schedule, any material, compound, mixture, or27 preparation which contains any quantity of the following28 hallucinogenic, psychedelic, or psychogenic substances, their salts,29 isomers, and salts of isomers whenever the existence of these salts,30 isomers, and salts of isomers is possible within the specific chemical31 designation (for purposes of this subsection only, the term "isomer"32 includes the optical, position, and geometric isomers):33 (1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name:34 TCPy.35 (2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). Some trade or36 other names: 4-Bromo-2, 5-Dimethoxy-a-methylphenethylamine;37 4-Bromo-2, 5-DMA.38 (3) 4-Bromo-2, 5-dimethoxyphenethylamine (7392). Some trade39 or other names:40 2-[4-bromo-2,5-dimethoxyphenyl ]-1-aminoe thane ;41 alpha-desmethyl DOB; 2C-B, Nexus.42 (4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name:
SB 631—LS 7594/DI 13
15
1 DOET.2 (5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348).3 Other name: 2C-T-7.4 (6) 2, 5-Dimethoxyamphetamine (7396). Some trade or other5 names: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.6 (7) 4-Methoxyamphetamine (7411). Some trade or other names:7 4-Methoxy-a-methylphenethylamine; Paramethoxyamphetamine;8 PMA.9 (8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). Other
10 Name: MMDA.11 (9) 5-Methoxy-N, N-diisopropyltryptamine, including any12 isomers, salts, or salts of isomers (7439). Other name:13 5-MeO-DIPT.14 (10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some trade15 and other names: 4-methyl-2,16 5-dimethoxy-a-methylphenethylamine; DOM; and STP.17 (11) 3, 4-methylenedioxy amphetamine (7400). Other name:18 MDA.19 (12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Other20 names: N-ethyl-alpha-methyl-3,4(methylenedioxy)21 phenethylamine; N-ethyl MDA; MDE; and MDEA.22 (13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).23 (14) 3, 4, 5-trimethoxy amphetamine (7390). Other name: TMA.24 (15) Alpha-ethyltryptamine (7249). Some trade and other names:25 Etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine;26 3-(2-aminobutyl) indole; [alpha]-ET; and AET.27 (16) Alpha-methyltryptamine (7432). Other name: AMT.28 (17) Bufotenine (7433). Some trade and other names:29 3-(B-Dimethylaminoethyl)-5-hydroxyindole;30 3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin;31 5-hydroxy-N, N-dimethyltryptamine; mappine.32 (18) Diethyltryptamine (7434). Some trade or other names: N,33 N-Diethyltryptamine; DET.34 (19) Dimethyltryptamine (7435). Some trade or other names:35 DMT.36 (20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6, 6b,37 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido38 (1', 2': 1, 2, azepino 4, 5-b) indole; tabernanthe iboga.39 (21) Lysergic acid diethylamide (7315). Other name: LSD.40 (22) Marijuana (7360).41 (23) Mescaline (7381).42 (24) Parahexyl (7374). Some trade or other names:
SB 631—LS 7594/DI 13
16
1 3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6,2 9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.3 (25) Peyote (7415), including:4 (A) all parts of the plant that are classified botanically as5 lophophora williamsii lemaire, whether growing or not;6 (B) the seeds thereof;7 (C) any extract from any part of the plant; and8 (D) every compound, manufacture, salt, derivative, mixture, or9 preparation of the plant, its seeds, or extracts.
10 (26) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.11 (27) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Other12 names: N-hydroxy-alpha-methyl-3,413 (methylenedioxy)phenethylamine; and N-hydroxy MDA.14 (28) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.15 (29) Psilocybin (7437).16 (30) Psilocyn (7438).17 (31) Tetrahydrocannabinols (7370), including synthetic18 equivalents of the substances contained in the plant, or in the19 resinous extractives of Cannabis, sp. and synthetic substances,20 derivatives, and their isomers with similar chemical structure and21 pharmacological activity such as:22 (A) ð cis or trans tetrahydrocannabinol, and their optical1
23 isomers;24 (B) ð cis or trans tetrahydrocannabinol, and their optical6
25 isomers; and26 4(C) ð cis or trans tetrahydrocannabinol, and their optical3,
27 isomers.28 Since nomenclature of these substances is not internationally29 standardized, compounds of these structures, regardless of30 numerical designation of atomic positions are covered. Other31 name: THC.32 (32) Ethylamine analog of phencyclidine (7455). Some trade or33 other names: N-Ethyl-1-phenylcyclohexylamine;34 (1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl)35 ethylamine; cyclohexamine; PCE.36 (33) Pyrrolidine analog of phencyclidine (7458). Some trade or37 yother names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCP ; PHP.38 (34) Thiophene analog of phencyclidine (7470). Some trade or39 other names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-Thienyl40 Analog of Phencyclidine; TPCP.41 (35) Salvia divinorum or salvinorin A, including:42 (A) all parts of the plant that are classified botanically as salvia
SB 631—LS 7594/DI 13
17
1 divinorum, whether growing or not;2 (B) the seeds of the plant;3 (C) any extract from any part of the plant; and4 (D) every compound, manufacture, salt, derivative, mixture, or5 preparation of the plant, its seeds, or extracts.6 (36) 5-Methoxy-N,N-Dimethyltryptamine. Some trade or other7 names: 5-methoxy-3-[2- (dimethylamino)ethyl]indole;8 5-MeO-DMT.9 (37) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
10 (38) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).11 (39) 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C).12 (40) 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I).13 (41) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl] ethanamine (2C-T-2).14 (42) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] ethanamine15 (2C-T-4).16 (43) 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H).17 (44) 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N).18 (45) 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P).19 (46) Deschloroketamine (2-Phenyl-2-20 (methylamino)cyclohexanone).21 (47) 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-22 ethyltryptamine).23 (48) N-methyltryptamine (1H-Indole-3-ethanamine, N-methyl-).24 (e) Depressants. Unless specifically excepted in a rule adopted by25 the board or unless listed in another schedule, any material, compound,26 mixture, or preparation which contains any quantity of the following27 substances having a depressant effect on the central nervous system,28 including its salts, isomers, and salts of isomers whenever the existence29 of such salts, isomers, and salts of isomers is possible within the30 specific chemical designation:31 Etizolam (4-(2- chlorophenyl)-2- ethyl-9- methyl- 6H-32 thieno[3,2-f] [1,2,4] triazolo[4,3-a] [1,4diazepine) (other names33 include: Etilaam, Etizest, Depas, Etizola, Sedekopan, and34 Pasaden)35 Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-36 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)37 Gamma-hydroxybutyric acid (other names include GHB;38 gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodium39 oxybate; sodium oxybutyrate) (2010)40 Mecloqualone (2572)41 Methaqualone (2565)42 (f) Stimulants. Unless specifically excepted or unless listed in
SB 631—LS 7594/DI 13
18
1 another schedule, any material, compound, mixture, or preparation that2 contains any quantity of the following substances having a stimulant3 effect on the central nervous system, including its salts, isomers, and4 salts of isomers:5 ([+/-]) cis-4-methylaminorex (([+/-])cis-4,5-6 dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590)7 Aminorex (1585). Other names: aminoxaphen;8 2-amino-5-phenyl-2-oxazoline; or9 4,5-dihydro-5-phenyl-2-oxazolamine.
10 Cathinone (1235). Some trade or other names:11 2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone;12 2-aminopropiophenone; and norephedrone.13 Fenethylline (1503).14 N-Benzylpiperazine (7493). Other names: BZP; and15 1-benzylpiperazine.16 N-ethylamphetamine (1475).17 Methcathinone (1237). Some other trade names:18 2-Methylamino-1-Phenylpropan-I-one; Ephedrone;19 Monomethylpropion; UR 1431.20 N, N-dimethylamphetamine (1480). Other names: N,21 N-a l pha - t r i me t hyl -benzenee thanamine ; and N,22 N-alpha-trimethylphenethylamine.23 (g) Synthetic drugs as defined in IC 35-31.5-2-321.24 SECTION 5. IC 35-48-2-6, AS AMENDED BY P.L.89-2018,25 SECTION 3, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE26 JULY 1, 2019]: Sec. 6. (a) The controlled substances listed in this27 section are included in schedule II.28 (b) Any of the following substances, except those narcotic drugs29 listed in other schedules, whether produced directly or indirectly by30 extraction from substances of vegetable origin, or independently by31 means of chemical synthesis, or by combination of extraction and32 chemical synthesis:33 (1) Opium and opiate, and any salt, compound, derivative, or34 preparation of opium or opiate, excluding apomorphine,35 dextrorphan, nalbuphine, naloxone, naltrexone, and their36 respective salts but including:37 (A) raw opium (9600);38 (B) opium extracts (9610);39 (C) opium fluid extracts (9620);40 (D) powdered opium (9639);41 (E) granulated opium (9640);42 (F) tincture of opium (9630);
SB 631—LS 7594/DI 13
19
1 (G) codeine (9050);2 (H) dihydroetorphine (9334);3 (I) ethylmorphine (9190);4 (J) etorphine hydrochloride (9059);5 (K) hydrocodone (9193), and any hydrocodone combination6 product, as determined by the federal Food and Drug7 Administration;8 (L) hydromorphone (9150);9 (M) metopon (9260);
10 (N) morphine (9300);11 (O) oxycodone (9143);12 (P) oxymorphone (9652);13 (Q) thebaine (9333); and14 (R) oripavine.15 (2) Any salt, compound, isomer, derivative, or preparation thereof16 which is chemically equivalent or identical with any of the17 substances referred to in subdivision (b)(1) of this section, but not18 including the isoquinoline alkaloids of opium.19 (3) Opium poppy and poppy straw.20 (4) Cocaine (9041).21 (5) Concentrate of poppy straw (the crude extract of poppy straw22 in either liquid, solid, or powder form which contains the23 phenanthrene alkaloids of the opium poppy) (9670).24 (c) Opiates. Any of the following opiates, including their isomers,25 esters, ethers, salts, and salts of isomers, esters, and ethers whenever26 the existence of these isomers, esters, ethers, and salts is possible27 within the specific chemical designation:28 Alfentanil (9737)29 Alphaprodine (9010)30 Anileridine (9020)31 Bezitramide (9800)32 Bulk dextropropoxyphene (nondosage forms) (9273)33 Carfentanil (9743)34 Dihydrocodeine (9120)35 Diphenoxylate (9170)36 Fentanyl (9801)37 Isomethadone (9226)38 Levo-alphacetylmethadol (9648). Other names:39 Levo-alpha-acetylmethadol; levomethadyl acetate; and LAAM.40 Levomethorphan (9210)41 Levorphanol (9220)42 Metazocine (9240)
SB 631—LS 7594/DI 13
20
1 Methadone (9250)2 Methadone-Intermediate, 4-cyano-2-dimethyl-amino-4,3 4-diphenyl butane (9254)4 Moramide-Intermediate, 2-methyl-3-morpholino-1,5 1-diphenylpropane- carboxylic acid (9802)6 Pethidine (Meperidine) (9230)7 Pethidine-Intermediate- A, 4-cyano-1-methyl-4-phenylpiperidine8 (9232)9 Pethidine-Intermediate-B,
10 ethyl-4-phenylpiperidine-4-carboxylate (9233)11 Pethidine-Intermediate-C,1-methyl-4-phenylpiperidine-4-carbo12 xylic acid (9234)13 Phenazodine (9715)14 Piminodine (9730)15 Racemethorphan (9732)16 Racemorphan (9733)17 Remifentanil (9739)18 Sufentanil (9740)19 Tapentadol20 Thiafentanil21 (d) Stimulants. Any material compound, mixture, or preparation22 which contains any quantity of the following substances having a23 potential for abuse associated with a stimulant effect on the central24 nervous system:25 (1) Amphetamine, its salts, optical isomers, and salts of its optical26 isomers (1100).27 (2) Methamphetamine, including its salts, isomers, and salts of its28 isomers (1105).29 (3) Phenmetrazine and its salts (1631).30 (4) Methylphenidate (1724).31 (5) Lisdexamfetamine, its salts, its isomers, and salts of its32 isomers.33 (e) Depressants. Unless specifically excepted by rule of the board34 or unless listed in another schedule, any material, compound, mixture,35 or preparation which contains any quantity of the following substances36 having a depressant effect on the central nervous system, including its37 salts, isomers, and salts of isomers whenever the existence of such38 salts, isomers, and salts of isomers is possible within the specific39 chemical designation:40 Amobarbital (2125)41 Glutethimide (2550)42 Pentobarbital (2270)
SB 631—LS 7594/DI 13
21
1 Phencyclidine (7471)2 Secobarbital (2315)3 (f) Immediate precursors. Unless specifically excepted by rule of the4 board or unless listed in another schedule, any material, compound,5 mixture, or preparation which contains any quantity of the following6 substances:7 (1) Immediate precursor to amphetamine and methamphetamine:8 Phenylacetone (8501). Some trade or other names:9 phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl
10 ketone.11 (2) Immediate precursors to phencyclidine (PCP):12 (A) 1-phenylcyclohexylamine (7460); or13 (B) 1-piperidinocyclohexanecarbonitrile (PCC) (8603).14 ( 3 ) I m m e d i a t e p r e c u r s o r t o f e n t a n y l :15 4-Anilino-N-Phenethyl-4-Piperidine (ANPP).16 (g) Hallucinogenic substances:17 D r o n a b i n o l o r a l s o l u t i o n . O t h e r n a m e :18 (-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC).19 Nabilone (7379). Other name: (+/-)-trans-3-20 (1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy -6,21 6-dimethyl-9H-dibenzo [b,d] pyran-9-one.22 SECTION 6. IC 35-48-2-12, AS AMENDED BY P.L.283-2013,23 SECTION 4, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE24 JULY 1, 2019]: Sec. 12. (a) The controlled substances listed in this25 section are included in schedule V.26 (b) Narcotic drugs containing nonnarcotic active medicinal27 ingredients. Any compound, mixture, or preparation containing any of28 the following narcotic drugs, or their salts calculated as the free29 anhydrous base or alkaloid, in the following quantities, which shall30 include one (1) or more nonnarcotic active medicinal ingredients in31 sufficient proportion to confer upon the compound, mixture, or32 preparation, valuable medicinal qualities other than those possessed by33 the narcotic drug alone:34 (1) Not more than 200 milligrams of codeine per 100 milliliters35 or per 100 grams.36 (2) Not more than 100 milligrams of dihydrocodeine per 10037 milliliters or per 100 grams.38 (3) Not more than 100 milligrams of ethylmorphine per 10039 milliliters or per 100 grams.40 (4) Not more than 2.5 milligrams of diphenoxylate and not less41 than 25 micrograms of atropine sulfate per dosage unit.42 (5) Not more than 100 milligrams of opium per 100 milliliters or
SB 631—LS 7594/DI 13
22
1 per 100 grams.2 (6) Not more than 0.5 milligrams of difenoxin (9168), and not less3 than 25 micrograms of atropine sulfate per dosage unit.4 (c) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]5 butanamide)).6 Pregabalin (2782).7 (d) Pyrovalerone (1485).8 ( e ) La c o s a m i d e [ ( R ) - 2 -a c e t oa mi d o - N- b e n z yl -9 3-methoxy-propionamide].
10 (f) Epidiolex.
SB 631—LS 7594/DI 13
23
COMMITTEE REPORT
Madam President: The Senate Committee on Rules and LegislativeProcedure, to which was referred Senate Bill No. 631, has had the sameunder consideration and begs leave to report the same back to theSenate with the recommendation that said bill be AMENDED asfollows:
Delete everything after the enacting clause and insert the following:
(SEE TEXT OF BILL)
and when so amended that said bill be reassigned to the SenateCommittee on Corrections and Criminal Law.
(Reference is to SB 631 as introduced.)
BRAY, Chairperson
_____
COMMITTEE REPORT
Madam President: The Senate Committee on Corrections andCriminal Law, to which was referred Senate Bill No. 631, has had thesame under consideration and begs leave to report the same back to theSenate with the recommendation that said bill be AMENDED asfollows:
Page 1, between the enacting clause and line 1, begin a newparagraph and insert:
"SECTION 1. IC 35-31.5-2-130.5 IS ADDED TO THE INDIANACODE AS A NEW SECTION TO READ AS FOLLOWS[EFFECTIVE JULY 1, 2019]: Sec. 130.5. "Fentanyl relatedsubstance", for purposes of IC 35-48, has the meaning set forth inIC 35-48-1-16.6.".
Page 6, strike lines 16 through 17.Page 6, line 18, strike "(XXXX)" and insert "(WWWW)".Page 6, line 20, delete "(YYYY)" and insert "(XXXX)".Page 6, delete lines 22 through 37.Page 6, line 38, delete "(HHHHH)" and insert "(YYYY)".Page 6, line 41, delete "(IIIII)" and insert "(ZZZZ)".Page 7, line 1, delete "(JJJJJ)" and insert "(AAAAA)".
SB 631—LS 7594/DI 13
24
Page 7, line 4, delete "(KKKKK)" and insert "(BBBBB)".Page 7, line 6, delete "(LLLLL)" and insert "(CCCCC)".Page 7, line 9, delete "(MMMMM)" and insert "(DDDDD)".Page 7, line 12, delete "(NNNNN)" and insert "(EEEEE)".Page 7, line 15, delete "(OOOOO)" and insert "(FFFFF)".Page 7, line 18, delete "(PPPPP)" and insert "(GGGGG)".Page 7, delete lines 20 through 28.Page 7, line 29, delete "(TTTTT)" and insert "(HHHHH)".Page 7, line 31, delete "(UUUUU)" and insert "(IIIII)".Page 7, line 36, delete "(VVVVV)" and insert "(JJJJJ)".Page 7, line 39, delete "(WWWWW)" and insert "(KKKKK)".Page 8, line 1, delete "(XXXXX)" and insert "(LLLLL)".Page 8, line 3, delete "(YYYYY)" and insert "(MMMMM)".Page 10, between lines 33 and 34, begin a new paragraph and insert:"SECTION 4. IC 35-48-1-16.6 IS ADDED TO THE INDIANA
CODE AS A NEW SECTION TO READ AS FOLLOWS[EFFECTIVE JULY 1, 2019]: Sec. 16.6. "Fentanyl relatedsubstance" means any substance not listed in schedule I through Vof IC 35-48-2 that is structurally related to fentanyl by one (1) ormore of the following modifications:
(1) Replacement of the phenyl portion of the phenethyl groupby any monocycle, whether or not further substituted in or onthe monocycle.(2) Substitution in or on the phenethyl group with alkyl,alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitrogroups.(3) Substitution in or on the piperidine ring with alkyl,alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino,or nitro groups.(4) Replacement of the aniline ring with any aromaticmonocycle whether or not further substituted in or on thearomatic monocycle.(5) Replacement of the N-propionyl group by another acylgroup.
SECTION 5. IC 35-48-2-4, AS AMENDED BY P.L.89-2018,SECTION 2, IS AMENDED TO READ AS FOLLOWS [EFFECTIVEJULY 1, 2019]: Sec. 4. (a) The controlled substances listed in thissection are included in schedule I.
(b) Opiates. Any of the following opiates, including their isomers,esters, ethers, salts, and salts of isomers, esters, and ethers, unlessspecifically excepted by rule of the board or unless listed in anotherschedule, whenever the existence of these isomers, esters, ethers, and
SB 631—LS 7594/DI 13
25
salts is possible within the specific chemical designation:4-fluoroisobutyryl fentanylAcetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) (9815)A c e t y l f e n t a ny l ( Ot he r na me s i nc l ude :N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)Acetylmethadol (9601)Acrylfentanyl. Other name: N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamideAllylprodine (9602)Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)Alphacetylmethadol (9603)Alphameprodine (9604)Alphamethadol (9605)Alphamethylfentanyl (9814)Benzethidine (9606)Beta-hydroxy-3-methylfentanyl (9831). Other name:N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamideBeta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)Betacetylmethadol (9607)Betameprodine (9608)Betamethadol (9609)Betaprodine (9611)Clonitazene (9612)C y c l o p e n t y l f e n t a n y l . O t h e r n a m e :N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamideDextromoramide (9613)Diampromide (9615)Diethylthiambutene (9616)Difenoxin (9168)Dimenoxadol (9617)Dimepheptanol (9618)Dimethylthiambutene (9619)Dioxaphetyl butyrate (9621)Dipipanone (9622)Ethylmethylthiambutene (9623)Etonitazene (9624)Etoxeridine (9625)Fentanyl related substances.
SB 631—LS 7594/DI 13
26
Furanyl fentanyl.Furethidine (9626)Hydroxypethidine (9627)I s o b u t y r y l f e n t a n y l . O t h e r n a m e :N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramideKetobemidone (9628)Levomoramide (9629)Levophenacylmorphan (9631)M e t h o x y a c e t y l f e n t a n y l . O t h e r n a m e :2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenyl-propanimide](9813)3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9833)MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)Morpheridine (9632)N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl),including any isomers, salts, or salts of isomers (9818)N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl] 25 piperidin-4-yl]-N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-(2-thienyl)ethyl] -4- piperidinyl]- N-phenylpropanamide,(beta-hydroxythiofentanyl)N-(4-chlorophenyl)- N-(1-phenethylpiperidin-4-yl)isobutyramide (para-chloroisobutyryl fentanyl)N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide (ocfentanil)N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4 -yl) butyramide(para-fluorobutyryl fentanyl)N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, alsoknown as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide,(butyryl fentanyl)N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valerylfentanyl)N-(4-methoxyphenyl)-N-(1-phenethylpiperidin -4-yl)butyramide (para-methoxybutyryl fentanyl)N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide(thenylfentanyl), including any isomers, salts, or salts of isomers(9834)N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide(isobutyryl fentanyl)N - ( 1 - p h e n e t h y l p i p e r i d i n - 4 - y l ) -Nphenylcyclopentanecarboxamide (cyclopentyl fentanyl)
SB 631—LS 7594/DI 13
27
Noracymethadol (9633)Norlevorphanol (9634)Normethadone (9635)Norpipanone (9636)O c f e n t a n i l . O t h e r n a m e :N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamideOrtho-fluorofentanyl or 2-fluorofentanyl. Other name:N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamidePara-chloroi sobutyryl fentanyl . Other name:N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramideP a r a - f l u o r o b u t yr y l f e n t a n y l . O t h e r n a m e :N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramidePara-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide (9812)Pa r a -me t hoxybu t yr yl f en t anyl . Other name:N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramidePhenadoxone (9637)Phenampromide (9638)Phenomorphan (9647)Phenoperidine (9641)PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)Piritramide (9642)Proheptazine (9643)Properidine (9644)Propiram (9649)Racemoramide (9645)T e t r a h yd r o f u r a n y l f e n t a n y l . O t h e r n a m e :N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamideThiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4-piperidinyl]-propanamide) (9835)Tilidine (9750)Trimeperidine (9646)U47700 (3,4-dichloro- N- [2-dimethylamino)cyclohexyl]-N-methyl- benzamide)V a l e r y l f e n t a n y l . O t h e r n a m e :N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide
(c) Opium derivatives. Any of the following opium derivatives, theirsalts, isomers, and salts of isomers, unless specifically excepted by ruleof the board or unless listed in another schedule, whenever the
SB 631—LS 7594/DI 13
28
existence of these salts, isomers, and salts of isomers is possible withinthe specific chemical designation:
Acetorphine (9319)Acetyldihydrocodeine (9051)Benzylmorphine (9052)Codeine methylbromide (9070)Codeine-N-Oxide (9053)Cyprenorphine (9054)Desomorphine (9055)Dihydromorphine (9145)Drotebanol (9335)Etorphine (except hydrochloride salt) (9056)Heroin (9200)Hydromorphinol (9301)Methyldesorphine (9302)Methyldihydromorphine (9304)Morphine methylbromide (9305)Morphine methylsulfonate (9306)Morphine-N-Oxide (9307)Myrophine (9308)Nicocodeine (9309)Nicomorphine (9312)Normorphine (9313)Pholcodine (9314)Thebacon (9315)
(d) Hallucinogenic substances. Unless specifically excepted orunless listed in another schedule, any material, compound, mixture, orpreparation which contains any quantity of the followinghallucinogenic, psychedelic, or psychogenic substances, their salts,isomers, and salts of isomers whenever the existence of these salts,isomers, and salts of isomers is possible within the specific chemicaldesignation (for purposes of this subsection only, the term "isomer"includes the optical, position, and geometric isomers):
(1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name:TCPy.(2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). Some trade orother names: 4-Bromo-2, 5-Dimethoxy-a-methylphenethylamine;4-Bromo-2, 5-DMA.(3) 4-Bromo-2, 5-dimethoxyphenethylamine (7392). Some tradeor other names:2-[4-bromo-2 ,5-d imethoxyphenyl]-1-aminoethane ;alpha-desmethyl DOB; 2C-B, Nexus.
SB 631—LS 7594/DI 13
29
(4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name:DOET.(5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348).Other name: 2C-T-7.(6) 2, 5-Dimethoxyamphetamine (7396). Some trade or othernames: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.(7) 4-Methoxyamphetamine (7411). Some trade or other names:4-Methoxy-a-methylphenethylamine; Paramethoxyamphetamine;PMA.(8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). OtherName: MMDA.(9) 5-Methoxy-N, N-diisopropyltryptamine, including anyisomers, salts, or salts of isomers (7439). Other name:5-MeO-DIPT.(10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some tradeand other names: 4-methyl-2,5-dimethoxy-a-methylphenethylamine; DOM; and STP.(11) 3, 4-methylenedioxy amphetamine (7400). Other name:MDA.(12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Othernames: N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine; N-ethyl MDA; MDE; and MDEA.(13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).(14) 3, 4, 5-trimethoxy amphetamine (7390). Other name: TMA.(15) Alpha-ethyltryptamine (7249). Some trade and other names:Etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine;3-(2-aminobutyl) indole; [alpha]-ET; and AET.(16) Alpha-methyltryptamine (7432). Other name: AMT.(17) Bufotenine (7433). Some trade and other names:3-(B-Dimethylaminoethyl)-5-hydroxyindole;3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin;5-hydroxy-N, N-dimethyltryptamine; mappine.(18) Diethyltryptamine (7434). Some trade or other names: N,N-Diethyltryptamine; DET.(19) Dimethyltryptamine (7435). Some trade or other names:DMT.(20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6, 6b,7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido(1', 2': 1, 2, azepino 4, 5-b) indole; tabernanthe iboga.(21) Lysergic acid diethylamide (7315). Other name: LSD.(22) Marijuana (7360).(23) Mescaline (7381).
SB 631—LS 7594/DI 13
30
(24) Parahexyl (7374). Some trade or other names:3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6,9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.(25) Peyote (7415), including:
(A) all parts of the plant that are classified botanically aslophophora williamsii lemaire, whether growing or not;(B) the seeds thereof;(C) any extract from any part of the plant; and(D) every compound, manufacture, salt, derivative, mixture, orpreparation of the plant, its seeds, or extracts.
(26) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.(27) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Othernames: N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine; and N-hydroxy MDA.(28) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.(29) Psilocybin (7437).(30) Psilocyn (7438).(31) Tetrahydrocannabinols (7370), including syntheticequivalents of the substances contained in the plant, or in theresinous extractives of Cannabis, sp. and synthetic substances,derivatives, and their isomers with similar chemical structure andpharmacological activity such as:
(A) ð cis or trans tetrahydrocannabinol, and their optical1
isomers;(B) ð cis or trans tetrahydrocannabinol, and their optical6
isomers; and
4(C) ð cis or trans tetrahydrocannabinol, and their optical3,
isomers.Since nomenclature of these substances is not internationallystandardized, compounds of these structures, regardless ofnumerical designation of atomic positions are covered. Othername: THC.(32) Ethylamine analog of phencyclidine (7455). Some trade orother names: N-Ethyl-1-phenylcyclohexylamine;(1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl)ethylamine; cyclohexamine; PCE.(33) Pyrrolidine analog of phencyclidine (7458). Some trade or
yother names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCP ; PHP.(34) Thiophene analog of phencyclidine (7470). Some trade orother names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-ThienylAnalog of Phencyclidine; TPCP.(35) Salvia divinorum or salvinorin A, including:
SB 631—LS 7594/DI 13
31
(A) all parts of the plant that are classified botanically as salviadivinorum, whether growing or not;(B) the seeds of the plant;(C) any extract from any part of the plant; and(D) every compound, manufacture, salt, derivative, mixture, orpreparation of the plant, its seeds, or extracts.
(36) 5-Methoxy-N,N-Dimethyltryptamine. Some trade or othernames: 5-methoxy-3-[2- (dimethylamino)ethyl]indole;5-MeO-DMT.(37) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).(38) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).(39) 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C).(40) 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I).(41) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl] ethanamine (2C-T-2).(42) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] ethanamine(2C-T-4).(43) 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H).(44) 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N).(45) 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P).(46) Deschloroketamine (2-Phenyl-2-(methylamino)cyclohexanone).(47) 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).(48) N-methyltryptamine (1H-Indole-3-ethanamine, N-methyl-).
(e) Depressants. Unless specifically excepted in a rule adopted bythe board or unless listed in another schedule, any material, compound,mixture, or preparation which contains any quantity of the followingsubstances having a depressant effect on the central nervous system,including its salts, isomers, and salts of isomers whenever the existenceof such salts, isomers, and salts of isomers is possible within thespecific chemical designation:
Etizolam (4-(2- chlorophenyl)-2- ethyl-9- methyl- 6H-thieno[3,2-f] [1,2,4] triazolo[4,3-a] [1,4diazepine) (other namesinclude: Etilaam, Etizest, Depas, Etizola, Sedekopan, andPasaden)Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)Gamma-hydroxybutyric acid (other names include GHB;gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodiumoxybate; sodium oxybutyrate) (2010)Mecloqualone (2572)Methaqualone (2565)
SB 631—LS 7594/DI 13
32
(f) Stimulants. Unless specifically excepted or unless listed inanother schedule, any material, compound, mixture, or preparation thatcontains any quantity of the following substances having a stimulanteffect on the central nervous system, including its salts, isomers, andsalts of isomers:
([+/-]) cis-4-methylaminorex (([+/-])cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590)Aminorex (1585). Other names: aminoxaphen;2-amino-5-phenyl-2-oxazoline; or4,5-dihydro-5-phenyl-2-oxazolamine.Cathinone (1235). Some trade or other names:2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone;2-aminopropiophenone; and norephedrone.Fenethylline (1503).N-Benzylpiperazine (7493). Other names: BZP; and1-benzylpiperazine.N-ethylamphetamine (1475).Methcathinone (1237). Some other trade names:2-Methylamino-1-Phenylpropan-I-one; Ephedrone;Monomethylpropion; UR 1431.N, N-dimethylamphetamine (1480). Other names: N,N-a l pha - t r imethyl -benzenee t hanami ne ; and N,N-alpha-trimethylphenethylamine.
(g) Synthetic drugs as defined in IC 35-31.5-2-321.".Page 12, between lines 29 and 30, begin a new paragraph and insert:
"Thiafentanil".Page 14, line 13, delete "Pregabalin (2782)." and insert
"Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide)).
Pregabalin (2782).".Renumber all SECTIONS consecutively.
and when so amended that said bill do pass.
(Reference is to SB 631 as printed January 17, 2019.)
YOUNG M, Chairperson
Committee Vote: Yeas 8, Nays 1.
SB 631—LS 7594/DI 13
